Risk factors influence the arterial line patency in ICU-bound patients during COVID-19 pandemic: An observational cohort study-Reference-Cited by-同舟云学术

Risk factors influence the arterial line patency in ICU-bound patients during COVID-19 pandemic: An observational cohort study

Published:2023-05-04 Issue:1 Volume:39 Page:401-411
ISSN:1110-1849
Container-title:Egyptian Journal of Anaesthesia
language:en
Short-container-title:Egyptian Journal of Anaesthesia

Author:

Elgendy Hamed¹²^ORCID,Ganaw Adel³,Kumari Vipin⁴,Settu Vijay⁴,Chandra Prem⁵,Nafady-Hego Hanaa⁶^ORCID,Hilani Mohamad⁷,Ismail Hesham²^ORCID,Elkateeb Mohamed⁸^ORCID

Affiliation:

1. Department of Anaesthesia, Assiut University Hospitals, Assiut, Egypt

2. Department of Anaesthesia and Intensive Care, Al Wakrah Hospital, Hamad Medical Corporation, Doha, Qatar

3. Intensive Care Medicine Dept, Al Wakrah Hospital, Hamad Medical Corporation, Doha, Qatar

4. Obstetric Network, WCRC; Hamad Medical Corporation, Doha, Qatar

5. Statistics Department, Medical Research Center, Academic Health System, Hamad Medical Corporation, Doha, Qatar

6. Laboratory Department, Aspetar Orthopaedic and Sports Medicine Hospital, Doha, Qatar

7. Department of Anaesthesia and Intensive Care, HAMAD General Hospital, Hamad Medical Corporation, Doha, Qatar

8. Head of Critical Care and Pulmonary Medicine Dept, HMGH; Hamad Medical Corporation, Doha, Qatar

Funder

Hamad Medical Corporation

Publisher

Informa UK Limited

Subject

Anesthesiology and Pain Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/11101849.2023.2209411

Reference28 articles.

1. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy

2. Incidence of thrombotic complications in critically ill ICU patients with COVID-19

3. High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients

4. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

5. Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis